REVIEW
|
doi:10.20944/preprints202307.0979.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
breast cancer; microbiota; estrobolome; β-glucuronidase; dysbiosis; inhibitors; metabolomics; personalized medicine; review
Online: 14 July 2023 (07:08:34 CEST)